IP Think Tank Global Week in Review – 2 November 2007

Here is IP Think Tank’s weekly selection of top
intellectual property news breaking in the blogosphere and internet.

The biggest news this week was the injunction restraining implementation of the new USPTO Rules. While on a lighter (virtual) note, there’s now a patent and trade mark office on SecondLife…

Please join the discussion by adding your comments on any
of these stories, and please do let me know if you think we’ve missed
important, or if there is a source you think should be monitored.

can separately subscribe to the IP Thinktank Global week in Review at http://thinkipstrategy.com/subscribe/


  • More SecondLife IP litigation (copyright): (Patry Copyright Blog),
  • SecondLife patent and trademark office opens: (Impact),
  • The unanswered question in intellectual property (IP Think Tank),
  • Two big patent securitzations around the corner: (IAM),
  • Monetizing IP the (new) IBM way: (IP Think Tank),
  • Monsanto’s costly patent strategy mistake: (IP Think Tank),


  • Exploding the myths about China’s legal system: (China Law Blog),
  • GE wins trade secrets and unfair competition battle with Jiuxiang Electrial Technology Co. Ltd over use of information by former employee (Rouse & Co.),
  • China enacts amendment to TRIPS allowing
    compulsory patent
    licence system when public health emergencies occur (Rouse & Co.), (IPDragon), (IPKat), (ChinaDaily),
  • IP Injunctions on the rise in China (Rouse & Co.),


  • French implement IP Enforcement Directive: (IPKat),



  • Hungarian public broadcaster, Magyar Televizio, known affectionately by its acronym MTV, faces challenge from Viacomm’s MTV Musc Channel: (IPKat),


  • Ranbaxy sues Polish company over registration of ‘ranbaxy.ed’, but in the Delhi High Court…: (Poland-IP law),
  • The Biological Diversity Act: (SpicyIP),
  • IP and Traditional Medicine: (SpicyIP),
  • Internationalised Domain Names and India: (SpicyIP),
  • Organization of Pharmaceutical Producers of India, (OPPI) which represents foreign-owned drug firms reiteratee its
    demand for removal of the pre-grant opposition provision from the Indian patent law (citing misuse by generic companies): (livemint),
  • Lilly inked a deal with India-based Glenmark Pharmaceuticals to
    acquire rights to a portfolio of TRPV1 antagonist molecules, including a Phase
    II compound, GRC 6211, for osteoarthritic pain: (invivoblog),


  • 4 illegal music file-swappers face fines of 12 million Euro: (IPKat),

South Korea

  • Seoul Semiconductor wins appeal for damages and injunction against Itswell: (Semiconductor today),


  • Ranbaxy sues Polish company over registration of ‘ranbaxy.ed’, but in the Delhi High Court…: (Poland-IP law),


United States

%d bloggers like this: